Boothbay Fund Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$381K Buy
106,399
+14,757
+16% +$58.6K 0.01% 1502
2025
Q4
$322K Sell
91,642
-7,099
-7% -$24.3K 0.01% 1387
2025
Q3
$322K Buy
+98,741
New +$311K 0.01% 1412
2025
Q2
Sell
-50,270
Closed -$335K 1766
2025
Q1
$335K Sell
50,270
-1,860
-4% -$18.4K 0.01% 1019
2024
Q4
$655K Buy
52,130
+8,894
+21% +$134K 0.02% 784
2024
Q3
$799K Hold
43,236
0.02% 820
2024
Q2
$931K Sell
43,236
-21,936
-34% -$504K 0.03% 745
2024
Q1
$1.76M Buy
65,172
+16,891
+35% +$480K 0.05% 551
2023
Q4
$1.45M Sell
48,281
-83,911
-63% -$1.85M 0.05% 597
2023
Q3
$2.71M Buy
+132,192
New +$2.4M 0.09% 401
2018
Q4
Hold
0
892
2018
Q3
Hold
0
975
2018
Q2
Sell
-19,032
Closed -$360K 925
2018
Q1
$357K Buy
+19,032
New +$310K 0.06% 411
2017
Q4
Sell
-34,933
Closed -$249K 826
2017
Q3
$249K Buy
34,933
+16,922
+94% +$77.3K 0.05% 439
2017
Q2
$137K Sell
18,011
-6,098
-25% -$45.5K 0.04% 595
2017
Q1
$193K Buy
+24,109
New +$162K 0.05% 610

Other funds holding RCKT